Full-Time

Medical Science Liaison/Senior Medical Science Liaison

Sleep Medicine, Southeast Region

Posted on 5/23/2024

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops therapies for central nervous system conditions

Biotechnology

Senior

Florida, USA + 4 more

Requirements
  • Advanced degree: MD, PharmD, or PhD required
  • Preference for candidates with previous industry experience
  • Preference for candidates with neurology, neuroscience, psychiatry and/or sleep therapeutic experience
  • Candidate must reside within the geographic area
  • Ability to travel up to 75%, including overnight stays and weekend, as needed
  • Meet requirements for health industry representative credentialing to gain access to healthcare facilities within the territory
Responsibilities
  • Systematically identify and develop relationships with healthcare professionals (HCPs)
  • Provide fair and balanced scientific information to HCPs and internal business partners
  • Lead scientific discovery and communicate insights from peer-to-peer discussions with HCPs
  • Identify, analyze, and translate specific needs within the territory
  • Collaborate with internal partners to advance clinical and business objectives
  • Build and maintain technical and clinical expertise in major depressive disorder and other neuroscience therapeutic areas
  • Maintain knowledge of global and regional market issues and product knowledge
  • Contribute to the growth of the National Sleep Field Medical Team
  • Execute key job functions including documentation of field activities and submission of medical insights
  • Provide high-level support for company-sponsored trials and investigator-initiated research proposals

Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

With a dedicated focus on developing therapies for central nervous system conditions—such as depression, Alzheimer’s disease agitation, and fibromyalgia—this company stands out by addressing critical unmet medical needs with promising products like AXS-05 and AXS-07. The firm fosters a culture deeply committed to innovation and the development of therapies with novel mechanisms of action, showcasing strong potential in the medical field and enhancing patient care in areas with limited treatment options.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

12%

1 year growth

45%

2 year growth

277%